Project 4: Dynamics of X chromosome inactivation

$406,713P01FY2014GMNIH

Harvard University, Cambridge MA

Investigators

Linked publications & trials

Paper 39638999 Paper 39122712 Paper 37645830 Paper 36719724 Paper 35304421 Paper 35179489 Paper 35088712 Paper 34752748 Paper 34731163 Paper 34416176 Paper 34385432 Paper 34244697 Paper 34083519 Paper 32894169 Paper 32728215 Paper 32632336 Paper 32514123 Paper 31839570 Paper 31738164 Paper 31723143 Paper 31570708 Paper 31515224 Paper 31448565 Paper 30683753 Paper 30537984 Paper 30337375 Paper 30195438 Paper 30017590 Paper 29681539 Paper 29654311 Paper 29625035 Paper 29551301 Paper 29531288 Paper 29526697 Paper 29343869 Paper 29335281 Paper 28959968 Paper 28445466 Paper 28366588 Paper 28009305 Paper 27927715 Paper 27532820 Paper 27524623 Paper 27117702 Paper 27009974 Paper 26501952 Paper 26501951 Paper 26237226 Paper 26235340 Paper 26186193 Paper 26030444 Paper 25937281 Paper 25822089 Paper 25693565 Paper 25630241 Paper 25597875 Paper 25556833 Paper 25551762 Paper 25533951 Paper 25525883 Paper 25362363 Paper 25214588 Paper 25079558 Paper 24952596 Paper 24813856 Paper 24672748 Paper 24658644 Paper 24463464 Paper 24381249 Paper 24183602 Paper 24182315 Paper 24052944 Paper 23925113 Paper 23827707 Paper 23723417 Paper 23664763 Paper 23620514 Paper 23401553 Paper 23400093 Paper 23299938 Paper 23260147 Paper 23222703 Paper 23181609 Paper 23177476 Paper 22952239 Paper 22922161 Paper 22902786 Paper 22663078 Paper 22560080 Paper 22456710 Paper 22337053

Abstract

The mouse inner cell mass (ICM) and the embryonic stem (ES) cells derived from it contain two active X chromosomes. Similarly, nuclear reprogramming resets the state of X chromosome inactivation (XCI) in mouse induced pluripotent stem (IPS) cells, which also transcribe both of their X chromosomes. However, the proper status of dosage compensation in human pluripotent stem cells remains to be clarified. As the transcriptional networks that propagates the pluripotent state in mouse ES cells has been tightly linked to the regulation of X chromosome inactivation, it will be of substantial interest to determine whether these gene regulatory processes are also tightly coupled within human pluripotent stem cells. In addition, many diseases result from mutations in X-linked genes. As there is substantial interest in using reprogrammed cells for modeling these conditions in vitro, it will be critically important to understand the state of dosage compensation in both human IPS cells and their differentiated derivatives. Here we propose to combine reprogramming, stem cell and genomic approaches to understand the behavior of the inactive X chromosome during the generation, maintenance and differentiation of human IPS cells. Our specific aims are to: Aim 1) To determine whether female IPS cells inherit the inactive X chromosome of the somatic cells from which they are derived and to determine how stably they maintain this inactive X in the course of long-term culture. Aim 2) To determine whether the loss of cytological hallmarks of X chromosome inactivation is accompanied by X-chromosome-wide relaxation of DNA methylation, chromatin structure and transcriptional silencing. Aim 3) We will determine the specific culture conditions that contribute to instability of X chromosome inactivation that we have observed and identify culture conditions that allow proper maintenance of X chromosome-wide heterochromatin.

View original record on NIH RePORTER →